Cortex is developing an advanced, seamlessly integrated, comprehensive platform for evaluating and treating AFib. The company has assembled a proven team of highly skilled and experienced engineers and clinical experts focused on bringing this innovative suite of technologies to market.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/08/23 | $90,000,000 |
AI Life Sciences Ajax Health Hellman & Friedman  KKR | undisclosed |
